Final results from M72 AS01E TB Vaccine Trial
The final results from the M72AS01E TB vaccine study have been published in the New England Journal of Medicine. The vaccine demonstrated a 50% efficacy rate in the incidence of lung TB disease in HIV-negative adults, already infected with latent...
Beat TB drama production
Beat TB, a Welcome Trust funded street theater production which raised awareness about tuberculosis (TB) and vaccine research understanding amongst the broader public of the Worcester area. during 2016.
2018 Tb under the Spotlight Science Engagement
The “TB Under the Spotlight Science Engagement” programme was conceptualised and presented by South African Tuberculosis Vaccine Initiative (SATVI) with scientists from the Division of Molecular Biology and Human Genetics at Stellenbosch University...
New multi-functional TB blood test validated
Researchers the South African Tuberculosis Vaccine Initiative (SATVI), the Center for Global Infectious Disease Research(USA) and a large consortium of collaborators have developed a validated a new, simple blood-based test that has the potential to...
Community Engagement
Carina's Choice: SATVI collaborated with UCT Drama Department and Worcester Secondary School in developing this play which was performed by learners from Worcester Secondary School at 8 local high schools reaching approximately 8 000 adolescents in...


Tuesday, 20 October 2020
26 March 2020 Notice to SATVI study participants: COVID-19 Lockdown

Due to the lockdown announced by the South African President, we want to bring the following information to the attention of all participants in SATVI studies.

Publication Date:
Thu, 26 Mar 2020 - 18:30
15 March 2020 Research Blood transcriptional signatures for tuberculosis testing

Professors Mark Hatherill, Tom Scriba, Doctors Simon Mendelsohn & Mbandi have authored an article titled: "Blood transcriptional signatures for tuberculosis testing" appearing in the Lancet Respiratory Medicine

Publication Date:
Sat, 21 Mar 2020 - 20:30
4 March 2020 Best paper award for UCT TB vaccine research

A paper which UCT’s Professors Mark Hatherill, Robert Wilkinson, Tom Scriba, Drs. Michèle Tameris and Friedrich Thienemann played a key role, has been selected as the best paper of the year for 2019. 

Publication Date:
Sat, 07 Mar 2020 - 09:00
2 March 2020 - Clinical Development of New TB Vaccines: Recent Advances and Next Steps.

Professor Mark Hatherill has co-authored a journal article titled: "Clinical Development of New TB Vaccines: Recent Advances and Next Steps" appearing in the Frontiers in Microbiology journal. 

Publication Date:
Thu, 05 Mar 2020 - 22:30